PA
BDSX icon

Perceptive Advisors’s Biodesix BDSX Stock Holding History

Perceptive Advisors’s Portfolio BDSX Stock Details BDSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-108,694
Closed -$739K – 99
2025
Q4 		$739K Hold
108,694
– – 0.01% 111
2025
Q3 		$821K Hold
108,694
– – 0.02% 87
2025
Q2 		$613K Hold
108,694
– – 0.02% 79
2025
Q1 		$1.36M Hold
108,694
– – 0.05% 76
2024
Q4 		$3.33M Hold
108,694
– – 0.09% 78
2024
Q3 		$3.87M Hold
108,694
– – 0.08% 84
2024
Q2 		$3.33M Buy
+108,694
New +$3.1M 0.08% 87

Other funds holding BDSX

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
TAM
Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
SC
Stempoint Capital New York $522M AUM 281.95% 1-Year Est. Return

Perceptive Advisors's BDSX Position: Q1 2026 in Review

Perceptive Advisors sold out of Biodesix (BDSX) in Q1 2026, closing a stake of 108,694 shares — an estimated $739K sold.

Perceptive Advisors first reported a position in BDSX in Q2 2024 and held it in 7 quarters. The position peaked at $3.87M in Q3 2024. 40 funds tracked by Wall St. Rank hold BDSX as of Q1 2026.

  • Perceptive Advisors reported no remaining Biodesix position as of Q1 2026 after selling out during the quarter.
  • Perceptive Advisors sold 108,694 Biodesix shares in Q1 2026, an estimated $739K.
  • Perceptive Advisors first reported a position in Biodesix in Q2 2024 and held it in 7 quarters.
  • Perceptive Advisors's Biodesix position peaked at $3.87M in Q3 2024.
  • 40 funds tracked by Wall St. Rank held Biodesix as of Q1 2026.

Based on Perceptive Advisors's 13F filing for Q1 2026, filed 15 May 2026.